ESPE Abstracts

^aUniversity of Manchester, Manchester, UK; ^bRoyal Manchester Children’s Hospital, Manchester, UK

^aUniversity of Manchester, Manchester, UK; ^bRoyal Manchester Children’s Hospital, Manchester, UK

^aUniversity of Manchester, Manchester, UK; ^bRoyal Manchester Children’s Hospital, Manchester, UK

^aUCL Institute of Child Health, London, UK; ^bQueen Mary, William Harvey Heart Centre, London, UK; ^cInstitute of Biomedical and Clinical Science, University of Exeter, Exeter, UK; ^dLondon Centre for Paediatric Endocrinology and Metabolism, Great Ormond Street Hospital, London, UK

^aCook Children’s Medical Center, Fort Worth, Texas, USA; ^bXeris Pharmaceuticals, Inc., Austin, Texas, USA; ^cChildren’s Hospital, O.v.G-University, Magdeburg, Germany; ^dDepartment of Paediatric Endocrinology, Royal Manchester Children’s Hospital, Manchester, UK

^aService Endocrinologie, Gynécologie et Diabétologie Pédiatrique, AP-HP, Hôpital Universitaire Necker Enfants Malades, Paris, France; ^bFaculté de Médecine Paris Descartes, Université Sorbonne Paris Cité, Paris, France; ^cUMRS 1138, Faculté de Médicine Paris Descartes, Centre de Recherche des Cordeliers, Paris, France; ^dUnité de Recherche Clinique, AP-HP, Hôpital Universitaire Necker Enfants Malades, Centre d’Investigation Clinique, Paris, France